Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial

BACKGROUND: Viruses from 2 influenza B lineages co-circulate, leading to suboptimal protection with trivalent influenza vaccines (TIV). Quadrivalent influenza vaccines (QIV) containing both lineages offer broader protection. METHODS: We compared inactivated seasonal QIV versus TIV (15 and 7.5 μg hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Long, Chandrasekaran, Vijayalakshmi, Domachowske, Joseph B., Li, Ping, Innis, Bruce L., Jain, Varsha K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407130/
https://www.ncbi.nlm.nih.gov/pubmed/26407273
http://dx.doi.org/10.1093/jpids/piv041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407130/
https://www.ncbi.nlm.nih.gov/pubmed/26407273
http://dx.doi.org/10.1093/jpids/piv041

Ejemplares similares